This mechanism may enable tumor-initiating cells to evade immune surveillance, thereby promoting CRC progression.[40] The interaction between IL-4 and its receptor leads to the phosphorylation of signal transducer and activator of transcription-6 in hematopoietic and epithelial cells. The gene discussed is IL4; the disease is colorectal carcinoma.